{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:27:55Z","timestamp":1787120875220,"version":"build-2736575974"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>China bears the highest global burden of esophageal cancer, with esophageal squamous cell carcinoma representing the predominant histological subtype. The poor clinical outcome of ESCC is largely attributable to its aggressive invasiveness and early metastatic spread. Currently, effective first-line targeted therapies remain limited, underscoring the need to identify actionable molecular targets and develop novel targeted agents for ESCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>XIAP expression was examined by Western blot analysis. Cell proliferation was assessed using CCK-8 assays, while cell migration and invasion were evaluated by wound-healing and Transwell assays. The interaction between W-1-32 and XIAP was investigated using drug affinity responsive target stability and cellular thermal shift assays. Molecular docking and molecular dynamics simulations were employed to explore the binding mode of W-1-32 to XIAP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A small-molecule compound, W-1-32, was identified as a modulator of XIAP. Computational analyses suggested a stable binding mode between W-1-32 and XIAP mediated by hydrogen bonding and noncovalent interactions, which was further supported by DARTS and CETSA assays. Treatment with W-1-32 reduced XIAP protein abundance in ESCC cells and was associated with decreased cell proliferation and migratory capacity. Notably, W-1-32 exhibited lower cytotoxicity toward normal esophageal epithelial cells compared with ESCC cells, indicating a degree of tumor selectivity\n                      <jats:italic>in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our results confirmed that W-1-32 significantly reduces ESCC cell proliferation and migration, which may be attributed to its binding to XIAP and the consequent reduction of XIAP protein levels. These findings identify W-1-32 as a XIAP-modulating compound with selective\n                      <jats:italic>in vitro<\/jats:italic>\n                      activity against ESCC cells, warranting further\n                      <jats:italic>in vivo<\/jats:italic>\n                      pharmacokinetic, efficacy, and safety evaluation before translational consideration.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1902572","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:47:49Z","timestamp":1787118469000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A highly potent compound W-1-32 targeting XIAP protein inhibits proliferation and metastasis of esophageal squamous cell carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuxiang","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifen","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Second Military Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.csbj.2019.01.009","article-title":"Targeting the BIR domains of inhibitor of apoptosis (IAP) proteins in cancer treatment","volume":"17","author":"Cossu","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/ijo.2019.4804","article-title":"The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway","volume":"55","author":"Coyle","year":"2019","journal-title":"Int. J. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1021\/acs.jcim.2c00140","article-title":"Mechanistic modeling of monoglyceride lipase covalent modification elucidates the role of leaving group expulsion and discriminates inhibitors with high and low potency","volume":"62","author":"Galvani","year":"2022","journal-title":"J. Chem. Inf. Model"},{"key":"B4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s10142-025-01660-8","article-title":"Integration of scRNA-seq and bulk tissue RNA-Seq data to identify cancer-associated fibroblast-related gene RGMA as a potential treatment target for esophageal cancer","volume":"25","author":"Gao","year":"2025","journal-title":"Funct. Integr. Genomics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"102870","DOI":"10.1016\/j.sbi.2024.102870","article-title":"Quantum mechanical-based strategies in drug discovery: finding the pace to new challenges in drug design","volume":"87","author":"Ginex","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.3390\/ijms26073262","article-title":"Application of density functional theory to molecular engineering of pharmaceutical formulations","volume":"26","author":"Guan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cancers13010141","article-title":"Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13578-019-0338-3","article-title":"X-linked inhibitor of apoptosis protein accelerates migration by inducing epithelial-mesenchymal transition through TGF-\u03b2 signaling pathway in esophageal cancer cells","volume":"9","author":"Jin","year":"2019","journal-title":"Cell Biosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0186658","DOI":"10.1371\/journal.pone.0186658","article-title":"Expression and function of the miR-143\/145 cluster in vitro and in vivo in human breast cancer","volume":"12","author":"Johannessen","year":"2017","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/tox.22450","article-title":"XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells","volume":"32","author":"Lee","year":"2017","journal-title":"Environ. Toxicol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ygeno.2021.02.003","article-title":"XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma","volume":"113","author":"Lou","year":"2021","journal-title":"Genomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s10637-020-00923-4","article-title":"Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists","volume":"38","author":"\u0141upicka-S\u0142owik","year":"2020","journal-title":"Invest New Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.saa.2013.09.015","article-title":"Quantum chemical and experimental studies on the structure and vibrational spectra of an alkaloid--Corlumine","volume":"118","author":"Mishra","year":"2014","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/cancers11091336","article-title":"XIAP as a target of new small organic natural molecules inducing human cancer cell death","volume":"11","author":"Mu\u00f1oz","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdx279","article-title":"International cancer seminars: a focus on esophageal squamous cell carcinoma","volume":"28","author":"Murphy","year":"2017","journal-title":"Ann. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1615\/CritRevOncog.2016017032","article-title":"The IAP protein family, SMAC mimetics and cancer treatment","volume":"21","author":"Philchenkov","year":"2016","journal-title":"Crit. Reviews Oncogenesis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4155\/fmc-2017-0198","article-title":"Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancer","volume":"10","author":"Prabhu","year":"2018","journal-title":"Future Med. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.acr.2019.05.004","article-title":"Clinical and translational advances in esophageal squamous cell carcinoma","volume":"144","author":"Reichenbach","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molstruc.2018.10.001","article-title":"Experimental and density functional theory (MEP, FMO, NLO, Fukui functions) and antibacterial activity studies on 2-amino-4- (4-nitrophenyl) -5,6-dihydrobenzo [h] quinoline-3-carbonitrile","volume":"1178","author":"Uzun","year":"2019","journal-title":"J. Mol. Struct."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1370801","DOI":"10.3389\/fonc.2024.1370801","article-title":"Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2147\/ott.S209312","article-title":"Embelin promotes oncolytic vaccinia virus-mediated antitumor immunity through disruption of IL-6\/STAT3 signaling in lymphoma","volume":"13","author":"Wang","year":"2020","journal-title":"Onco Targets Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ijc.33421","article-title":"Research on esophageal cancer: with personal perspectives from studies in China and Kenya","volume":"149","author":"Yang","year":"2021","journal-title":"Int. J. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-020-00323-3","article-title":"Advances in targeted therapy for esophageal cancer","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12935-025-03791-1","article-title":"Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker","volume":"25","author":"Yang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11010-018-3479-5","article-title":"Concomitance of downregulated active caspase-3 and upregulated X-chromosome linked inhibitor of apoptosis protein as a sensitive diagnostic approach for breast cancer","volume":"455","author":"Zohny","year":"2019","journal-title":"Mol. Cell Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1902572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:47:50Z","timestamp":1787118470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1902572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":25,"alternative-id":["10.3389\/fphar.2026.1902572"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1902572","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1902572"}}